Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

Overview of attention for article published in Cardiovascular Diabetology, September 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 23,564 followers.

@AmarPut @singhak_endo The EMBODY trial had also provided some preliminary evidence and fueled expectations https://t.co/a79kckhM1y

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.